Thrive Global March 24, 2020
Christina Warner

I had the pleasure to interview Dan Rhodes, PhD, Co-founder and CEO, Strata Oncology. Dan is co-founder and CEO of Strata Oncology. Previously, he was Vice President of Oncology Strategy at Thermo Fisher Scientific (Life Technologies) where he led cancer sequencing product development and companion diagnostic partnerships. Before that, Dan co-founded and was CEO of Compendia Bioscience, a cancer genomics data company, acquired by Life Technologies in 2012. Dan holds a PhD in Bioinformatics from the University of Michigan.

Thank you so much for doing this with us! Can you tell us a story about what brought you to this specific career path?

In 1999, I was a junior at the University of Michigan, sitting in a molecular biology lecture...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Healthcare System, Insurance, Market Research, Payment Models, Provider, Trends, Value Based
Overweight, Obesity to Affect 64% of Americans by 2050
Another year, higher healthcare prices: Are employers ready for 2025?
Jefferson Health's safety secret: Resilience engineering
What Trump's presidency could spell for the CDC: 5 notes
Technically sound, socially responsible and accessible AI: New framework champions equity in AI for health care

Share This Article